Background Primary cardiac angiosarcomas are uncommon, but they will be the most intense type of principal cardiac neoplasms. end up being inhibited with particular KDR inhibitors in vitro. Hence, sufferers harboring activating mutations could possibly be applicants for treatment with KDR-specific inhibitors. Electronic supplementary materials The online edition of this content (doi:10.1186/s12885-016-3000-z) contains supplementary materials,… Continue reading Background Primary cardiac angiosarcomas are uncommon, but they will be the